The cerebrospinal fluid management (csf) devices and equipment market size has grown strongly in recent years. It will grow from $1.21 billion in 2025 to $1.28 billion in 2026 at a compound annual growth rate (CAGR) of 5.8%. The growth in the historic period can be attributed to increasing diagnosis of hydrocephalus cases, expansion of neurosurgical treatment centers, rising adoption of shunt-based therapies, availability of advanced drainage systems, growing pediatric neurology care.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $1.64 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for smart and adjustable csf shunts, rising focus on infection-resistant materials, expansion of geriatric neurosurgical care, growing investments in neurological disorder management, technological advancements in intracranial pressure monitoring. Major trends in the forecast period include increasing adoption of programmable shunt systems, rising use of minimally invasive csf drainage devices, growing integration of pressure monitoring technologies, expansion of pediatric hydrocephalus treatments, enhanced focus on long-term patient management.
The increasing prevalence of neurological disorders is expected to drive the growth of the cerebrospinal fluid (CSF) devices market in the coming years. Neurological disorders are defined as conditions that affect the brain, spinal cord, and the nerves throughout the body. Cerebrospinal fluid (CSF) devices are used to diagnose, monitor, and treat these disorders, thereby improving patients’ quality of life. For example, according to the 2023 Alzheimer's Disease Facts and Figures by the Alzheimer's Association, Alzheimer’s and other dementias will cost the United States $345 billion in 2023, with projections reaching nearly $1 trillion by 2050. Consequently, the rising prevalence of neurological disorders is fueling the expansion of the cerebrospinal fluid (CSF) devices market.
The increase in brain surgeries is also contributing to the growth of the cerebrospinal fluid (CSF) devices market. CSF devices are critical in managing traumatic brain injury (TBI); shunts are commonly used to drain excess cerebrospinal fluid accumulated near the brain. In the United States, TBI is a leading cause of death, with approximately 1.5 to 2 million adults and children affected each year. Among the 1.1 million individuals who sustain head injuries, 235,000 are hospitalized with moderate to severe cases, while around 50,000 fatalities occur. The majority, however, experience mild injuries that do not require hospitalization. The rising incidence of brain injuries is therefore expected to sustain growth in the CSF devices market.
Companies in the CSF devices market are developing innovative products to meet unmet medical needs. One notable example is the ReFlow Mini Flusher device, designed to treat hydrocephalus, a condition characterized by excessive accumulation of cerebrospinal fluid in the brain. Launched in July 2023, this small, implantable system combines a flushing device with a ventricular catheter. Its compact design, ease of use, and reduced profile make it a promising advancement in hydrocephalus treatment.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market are Medtronic plc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Sophysa S.A, Spiegelberg GmbH & Co. KG, Natus Medical Incorporated, Möller Medical GmbH, Dispomedica GmbH, Raumedic AG, Christoph Miethke GmbH & Co. KG, Flowonix Medical Inc, Phoenix Biomedical Corporation, Orsan Medical Technologies, Beckersmith Medical Inc, SOMATEX Medical Technologies, Neurosign, Medsit Medical, Delta Surgical Limited, G. Surgiwear Ltd, Tokibo Co. Ltd, Nikkiso Co. Ltd, Medtronic Neuro.
North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2025. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cerebrospinal fluid management devices and equipment market by increasing costs of imported medical-grade polymers, valves, sensors, and precision tubing used in shunts and drainage systems. Hospitals in North America and Europe are most affected due to dependence on imported neurosurgical components, while Asia-Pacific faces manufacturing cost pressures. These tariffs are raising device prices and impacting procurement budgets. However, they are also supporting domestic production, localized component sourcing, and innovation in cost-effective CSF management technologies.
The cerebrospinal fluid management (csf) devices and equipment market research report is one of a series of new reports that provides cerebrospinal fluid management (csf) devices and equipment market statistics, including cerebrospinal fluid management (csf) devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid management (csf) devices and equipment market share, detailed cerebrospinal fluid management (csf) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid management (csf) devices and equipment industry. This cerebrospinal fluid management (csf) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cerebrospinal fluid management (CSF) devices and equipment play a crucial role in treating hydrocephalus, a condition characterized by the excessive accumulation of CSF within the brain.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
The cerebrospinal fluid management (csf) devices and equipment market size is expected to see strong growth in the next few years. It will grow to $1.64 billion in 2030 at a compound annual growth rate (CAGR) of 6.3%. The growth in the forecast period can be attributed to increasing demand for smart and adjustable csf shunts, rising focus on infection-resistant materials, expansion of geriatric neurosurgical care, growing investments in neurological disorder management, technological advancements in intracranial pressure monitoring. Major trends in the forecast period include increasing adoption of programmable shunt systems, rising use of minimally invasive csf drainage devices, growing integration of pressure monitoring technologies, expansion of pediatric hydrocephalus treatments, enhanced focus on long-term patient management.
The increasing prevalence of neurological disorders is expected to drive the growth of the cerebrospinal fluid (CSF) devices market in the coming years. Neurological disorders are defined as conditions that affect the brain, spinal cord, and the nerves throughout the body. Cerebrospinal fluid (CSF) devices are used to diagnose, monitor, and treat these disorders, thereby improving patients’ quality of life. For example, according to the 2023 Alzheimer's Disease Facts and Figures by the Alzheimer's Association, Alzheimer’s and other dementias will cost the United States $345 billion in 2023, with projections reaching nearly $1 trillion by 2050. Consequently, the rising prevalence of neurological disorders is fueling the expansion of the cerebrospinal fluid (CSF) devices market.
The increase in brain surgeries is also contributing to the growth of the cerebrospinal fluid (CSF) devices market. CSF devices are critical in managing traumatic brain injury (TBI); shunts are commonly used to drain excess cerebrospinal fluid accumulated near the brain. In the United States, TBI is a leading cause of death, with approximately 1.5 to 2 million adults and children affected each year. Among the 1.1 million individuals who sustain head injuries, 235,000 are hospitalized with moderate to severe cases, while around 50,000 fatalities occur. The majority, however, experience mild injuries that do not require hospitalization. The rising incidence of brain injuries is therefore expected to sustain growth in the CSF devices market.
Companies in the CSF devices market are developing innovative products to meet unmet medical needs. One notable example is the ReFlow Mini Flusher device, designed to treat hydrocephalus, a condition characterized by excessive accumulation of cerebrospinal fluid in the brain. Launched in July 2023, this small, implantable system combines a flushing device with a ventricular catheter. Its compact design, ease of use, and reduced profile make it a promising advancement in hydrocephalus treatment.
Major companies operating in the cerebrospinal fluid management (csf) devices and equipment market are Medtronic plc, Johnson & Johnson Services Inc, B. Braun Melsungen AG, Integra LifeSciences Holdings Corporation, Sophysa S.A, Spiegelberg GmbH & Co. KG, Natus Medical Incorporated, Möller Medical GmbH, Dispomedica GmbH, Raumedic AG, Christoph Miethke GmbH & Co. KG, Flowonix Medical Inc, Phoenix Biomedical Corporation, Orsan Medical Technologies, Beckersmith Medical Inc, SOMATEX Medical Technologies, Neurosign, Medsit Medical, Delta Surgical Limited, G. Surgiwear Ltd, Tokibo Co. Ltd, Nikkiso Co. Ltd, Medtronic Neuro.
North America was the largest region in the global cerebrospinal fluid (CSF) management devices and equipment market in 2025. Asia-Pacific was the second-largest region in the cerebrospinal fluid (CSF) management devices and equipment market. The regions covered in the cerebrospinal fluid management (csf) devices and equipment market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the cerebrospinal fluid management (csf) devices and equipment market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Tariffs are influencing the cerebrospinal fluid management devices and equipment market by increasing costs of imported medical-grade polymers, valves, sensors, and precision tubing used in shunts and drainage systems. Hospitals in North America and Europe are most affected due to dependence on imported neurosurgical components, while Asia-Pacific faces manufacturing cost pressures. These tariffs are raising device prices and impacting procurement budgets. However, they are also supporting domestic production, localized component sourcing, and innovation in cost-effective CSF management technologies.
The cerebrospinal fluid management (csf) devices and equipment market research report is one of a series of new reports that provides cerebrospinal fluid management (csf) devices and equipment market statistics, including cerebrospinal fluid management (csf) devices and equipment industry global market size, regional shares, competitors with a cerebrospinal fluid management (csf) devices and equipment market share, detailed cerebrospinal fluid management (csf) devices and equipment market segments, market trends and opportunities, and any further data you may need to thrive in the cerebrospinal fluid management (csf) devices and equipment industry. This cerebrospinal fluid management (csf) devices and equipment market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Cerebrospinal fluid management (CSF) devices and equipment play a crucial role in treating hydrocephalus, a condition characterized by the excessive accumulation of CSF within the brain.
The primary categories of cerebrospinal fluid (CSF) management devices and equipment include CSF shunts and CSF drainage systems. CSF shunts serve as the key devices for hydrocephalus treatment, featuring silastic tubes that redirect CSF from the ventricles to other body cavities, such as the peritoneum, the right cardiac atrium, or the pleural space. CSF drainage system types, including ventricular drainage systems and lumbar drainage systems, are utilized across different age groups, encompassing pediatric, adult, and geriatric patients. Hospitals and ambulatory surgical centers represent the various end-users of these devices.
The cerebrospinal fluid management (CSF) devices and equipment market consists of sales of ventricular drainage system, lumbar drainage system that are used for the treatment of hydrocephalus. Values in this market are factory gate values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
This product will be delivered within 1-3 business days.
Table of Contents
1. Executive Summary
2. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Characteristics
3. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Supply Chain Analysis
4. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Trends and Strategies
5. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Analysis of End Use Industries
7. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Strategic Analysis Framework, Current Market Size, Market Comparisons and Growth Rate Analysis
8. Global Cerebrospinal Fluid Management (CSF) Devices and Equipment Total Addressable Market (TAM) Analysis for the Market
9. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Segmentation
10. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Regional and Country Analysis
11. Asia-Pacific Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
12. China Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
13. India Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
14. Japan Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
15. Australia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
16. Indonesia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
17. South Korea Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
18. Taiwan Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
19. South East Asia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
20. Western Europe Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
21. UK Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
22. Germany Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
23. France Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
24. Italy Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
25. Spain Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
26. Eastern Europe Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
27. Russia Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
28. North America Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
29. USA Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
30. Canada Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
31. South America Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
32. Brazil Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
33. Middle East Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
34. Africa Cerebrospinal Fluid Management (CSF) Devices and Equipment Market
36. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Competitive Landscape and Company Profiles
37. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market Other Major and Innovative Companies
40. Cerebrospinal Fluid Management (CSF) Devices and Equipment Market High Potential Countries, Segments and Strategies
41. Appendix
List of Tables
Executive Summary
Cerebrospinal Fluid Management (CSF) Devices And Equipment Market Global Report 2026 provides strategists, marketers and senior management with the critical information they need to assess the market.This report focuses cerebrospinal fluid management (csf) devices and equipment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase:
- Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
- Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
- Create regional and country strategies on the basis of local data and analysis.
- Identify growth segments for investment.
- Outperform competitors using forecast data and the drivers and trends shaping the market.
- Understand customers based on end user analysis.
- Benchmark performance against key competitors based on market share, innovation, and brand strength.
- Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
- Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
- Report will be updated with the latest data and delivered to you along with an Excel data sheet for easy data extraction and analysis.
- All data from the report will also be delivered in an excel dashboard format.
Description
Where is the largest and fastest growing market for cerebrospinal fluid management (csf) devices and equipment? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The cerebrospinal fluid management (csf) devices and equipment market global report answers all these questions and many more.The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
- The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
- The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
- The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
- The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
- The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
- The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
- The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
- The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
- Market segmentations break down the market into sub markets.
- The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
- Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
- The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
- The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.
Report Scope
Markets Covered:
1) By Type: CSF Shunts; CSF Drainage Systems2) By Age Group: Pediatric; Adult; Geriatric
3) By End User: Hospitals; Ambulatory Surgical Centers
Subsegments:
1) By CSF Shunts: Ventriculoperitoneal (VP) Shunts; Ventriculoatrial (VA) Shunts; Lumboperitoneal (LP) Shunts2) By CSF Drainage Systems: External Ventricular Drainage (EVD) Systems; Lumbar Drainage Systems; Continuous Drainage Systems; Intermittent Drainage Systems
Companies Mentioned: Medtronic plc; Johnson & Johnson Services Inc; B. Braun Melsungen AG; Integra LifeSciences Holdings Corporation; Sophysa S.A; Spiegelberg GmbH & Co. KG; Natus Medical Incorporated; Möller Medical GmbH; Dispomedica GmbH; Raumedic AG; Christoph Miethke GmbH & Co. KG; Flowonix Medical Inc; Phoenix Biomedical Corporation; Orsan Medical Technologies; Beckersmith Medical Inc; SOMATEX Medical Technologies; Neurosign; Medsit Medical; Delta Surgical Limited; G. Surgiwear Ltd; Tokibo Co. Ltd; Nikkiso Co. Ltd; Medtronic Neuro
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time Series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita.
Data Segmentation: Country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery Format: Word, PDF or Interactive Report + Excel Dashboard
Added Benefits:
- Bi-Annual Data Update
- Customisation
- Expert Consultant Support
Companies Mentioned
The companies featured in this Cerebrospinal Fluid Management (CSF) Devices and Equipment market report include:- Medtronic plc
- Johnson & Johnson Services Inc
- B. Braun Melsungen AG
- Integra LifeSciences Holdings Corporation
- Sophysa S.A
- Spiegelberg GmbH & Co. KG
- Natus Medical Incorporated
- Möller Medical GmbH
- Dispomedica GmbH
- Raumedic AG
- Christoph Miethke GmbH & Co. KG
- Flowonix Medical Inc
- Phoenix Biomedical Corporation
- Orsan Medical Technologies
- Beckersmith Medical Inc
- SOMATEX Medical Technologies
- Neurosign
- Medsit Medical
- Delta Surgical Limited
- G. Surgiwear Ltd
- Tokibo Co. Ltd
- Nikkiso Co. Ltd
- Medtronic Neuro
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 250 |
| Published | February 2026 |
| Forecast Period | 2026 - 2030 |
| Estimated Market Value ( USD | $ 1.28 Billion |
| Forecasted Market Value ( USD | $ 1.64 Billion |
| Compound Annual Growth Rate | 6.3% |
| Regions Covered | Global |
| No. of Companies Mentioned | 23 |
